Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To demonstrate the immunogenicity of Sinovac rabies vaccine is non-inferior to the active-controlled rabies vaccine (Verorab®) after pre-exposure prophylaxis (PrEP) vaccination, and to confirm its satisfying safety profile in the pediatric and adult population in a PrEP schedule
Epistemonikos ID: e02557f8bf78f18b45c2b657aa68d55e12fe30ff
First added on: Jul 09, 2025